Use of PCR for prenatal and postnatal diagnosis of congenital rubella.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 228600)

Published in J Clin Microbiol on November 01, 1995

Authors

T J Bosma1, K M Corbett, M B Eckstein, S O'Shea, P Vijayalakshmi, J E Banatvala, K Morton, J M Best

Author Affiliations

1: Department of Virology, United Medical School, Guys Hospital, London, United Kingdom.

Articles cited by this

Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56

Prenatal diagnosis. N Engl J Med (1993) 3.73

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94

Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48

VIROLOGIC AND SEROLOGIC STUDIES ON HUMAN PRODUCTS OF CONCEPTION AFTER MATERNAL RUBELLA. N Engl J Med (1964) 2.40

Prenatal diagnosis of congenital rubella. Lancet (1984) 2.31

The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02

Complete sequence of a gene encoding a human type I keratin: sequences homologous to enhancer elements in the regulatory region of the gene. Proc Natl Acad Sci U S A (1985) 1.78

The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue. J Virol Methods (1994) 1.62

Isolation of rubella virus from abortion material. Br Med J (1970) 1.48

Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol (1993) 1.48

PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47

Intrauterine diagnosis of cytomegalovirus and rubella infections by amniocentesis. CMAJ (1991) 1.43

Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1994) 1.32

Detection of rubella virus gene sequences by enzymatic amplification and direct sequencing of amplified DNA. J Clin Microbiol (1991) 1.25

Prenatal diagnosis of intrauterine rubella. Infection (1987) 1.21

Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus. J Clin Microbiol (1994) 1.20

Rubella in Europe. Epidemiol Infect (1991) 1.18

Reverse transcription and subsequent DNA amplification of rubella virus RNA. J Virol Methods (1989) 1.11

Detection of the human papilloma virus type 16 mRNA-transcripts in cytological abnormal scrapings. J Med Virol (1992) 1.04

Persistence of virus in lens for three years after prenatal rubella. Lancet (1967) 1.03

Diagnosis of foetal rubella virus infection by polymerase chain reaction. J Gen Virol (1990) 1.01

Rubella surveillance to December 1992: second joint report from the PHLS and National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1993) 1.00

Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev (1991) 0.96

Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection. Obstet Gynecol (1993) 0.96

Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy. Prenat Diagn (1989) 0.91

Cytomegalovirus fetal infection: prenatal diagnosis. Obstet Gynecol (1991) 0.91

Rubella in the developing world. Epidemiol Infect (1991) 0.88

Prenatal diagnosis of congenital rubella. Br Med J (1977) 0.84

Outcome of pregnancy after maternal reinfection with rubella. CDR (Lond Engl Rev) (1991) 0.83

Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol (1994) 0.81

[Rubella embryopathy, still now? (author's transl)]. Geburtshilfe Frauenheilkd (1982) 0.77

Articles by these authors

A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70

HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46

Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16

A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07

Hepatitis A. BMJ (1991) 3.77

Nutritional studies of Histoplasma capsulatum. Mycopathol Mycol Appl (1965) 2.96

Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76

Liver disease among homosexual males. Lancet (1979) 2.74

Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48

Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J Clin Microbiol (1993) 2.45

Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33

In-vitro detection of human rotaviruses. Lancet (1975) 2.28

Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol (1986) 2.21

Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08

Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07

Hepatitis B infections after gynaecological surgery. Lancet (1989) 1.99

New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99

Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94

Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93

Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92

Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92

Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med (1996) 1.87

The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86

Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86

Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85

Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. J Med Genet (2002) 1.84

Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ (1999) 1.79

Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78

Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78

Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73

Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71

Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J Virol Methods (1994) 1.67

Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66

Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66

Effect of pranayam training on cardiac function in normal young volunteers. Indian J Physiol Pharmacol (2003) 1.60

A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59

Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59

Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing? Ann R Coll Surg Engl (1996) 1.58

Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58

Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children. J Med Virol (1983) 1.57

Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56

Aetiology of childhood cataract in south India. Br J Ophthalmol (1996) 1.54

Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet (1980) 1.54

Herpes genitalis; clinical and virological studies. Br J Vener Dis (1967) 1.50

Effect of slow and fast pranayams on reaction time and cardiorespiratory variables. Indian J Physiol Pharmacol (2006) 1.49

PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47

Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology (1997) 1.46

Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40

bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40

Letter: Polio vaccination for travellers. Br Med J (1975) 1.39

Measles must go and with it rubella. Br Med J (Clin Res Ed) (1987) 1.38

Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38

Veterinary nursing examinations. Vet Rec (1994) 1.38

Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33

Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33

Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32

Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30

Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30

Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30

New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26

Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26

Hepatitis A antibodies in London blood donors, medical students, and patients. Lancet (1980) 1.24

Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis (1999) 1.23

Corneal stromal wound healing in rabbits after 193-nm excimer laser surface ablation. Arch Ophthalmol (1989) 1.21

A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods (1984) 1.21

Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol (1987) 1.20

Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet (1989) 1.19

Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19

Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18

Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol (2000) 1.17

Randomised clinical trial of lensectomy versus lens aspiration and primary capsulotomy for children with bilateral cataract in south India. Br J Ophthalmol (1999) 1.16